Trials / Unknown
UnknownNCT04702685
Erector Spinae Plane Block With Ropivacaine for Major Upper Abdominal Surgery
A Single Center, Randomized, Parallel Group Study to Evaluate the Efficacy of Ropivacaine Administered by Ultrasound-guided Erector Spinae Plane Block for Major Upper Abdominal Surgery
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Nazarbayev University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, single-centre, randomized, controlled, open-label, evaluator-blinded, superiority trial.
Detailed description
The primary objective is to establish whether ESP ropivacaine reduces post-operative opioid use and improves pain rating post-operatively. The secondary objectives include adverse event incidence, time to ambulation and time to discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | Local anesthetic for injection |
| OTHER | Placebo | Bandage will be placed in the presumed injection site while patients in under general anesthesia |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-05-01
- Completion
- 2021-08-01
- First posted
- 2021-01-11
- Last updated
- 2021-01-11
Locations
1 site across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT04702685. Inclusion in this directory is not an endorsement.